Gene expression profiling in schizophrenia and related mental disorders

Neuroscientist

Volumn 12, Issue 4, 2006, Pages 349-361

  Iwamoto, Kazuya ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Bipolar disorder; DNA microarray; Major depression; Postmortem

Indexed keywords

COMPLEMENTARY DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MALATE DEHYDROGENASE; NEUROPEPTIDE Y RECEPTOR; RNA;

AUTOPSY; BIPOLAR DISORDER; BLOOD; BLOOD SAMPLING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA LIBRARY; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR DEPRESSION; MENTAL DISEASE; MUTATION; OLIGODENDROGLIA; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHIZOPHRENIA; STATISTICAL ANALYSIS;

BIPOLAR DISORDER; DEPRESSION; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 33745881631     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858406287536     Document Type: Review

References (102)

1. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, and others. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58:85-96.
2. Aston C, Jiang L, Sokolov BP. 2004. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77:858-66.
3. Aston C, Jiang L, Sokolov BP. 2005. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10:309-22.
4. Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC. 2001. Gene expression profiling in the post-mortem human brain - no cause for dismay. J Chem Neuroanat 22:79-94.
5. Barton AJ, Pearson RC, Najlerahim A, Harrison PJ. 1993. Pre- and postmortem influences on brain RNA. J Neurochem 61:1-11.
6. Ben-Shachar D, Laifenfeld D. 2004. Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol 59:273-96.
7. Berrettini WH. 2000. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 48:531-8.
8. Bezchlibnyk YB, Wang JF, McQueen GM, Young LT. 2001. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem 79:826-34.
9. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, and others. 2000. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 18:630-1.
10. Bromet EJ, Fennig S. 1999. Epidemiology and natural history of schizophrenia. Biol Psychiatry 46:871-81.
11. Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, and others. 2003. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 160:657-66.
12. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, and others. 2003. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 33:422-5.
13. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, and others. 2005. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102:15653-8.
14. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, and others. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11:1373-80.
15. Chung C, Tallerico T, Seeman P. 2003. Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 50:29-34.
16. Cichon S, Buervenich S, Kirov G, Akula N, Dimitrova A, Green E, and others. 2004. Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nat Genet 36:783-4: author reply 4-5.
17. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, and others. 2005. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175.
18. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, and others. 2003. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60:443-56.
19. Debey S, Schoenbeck U, Hellmich M, Gathof BS, Pillai R, Zander T, and others. 2004. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 4:193-207.
20. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. 2006. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis 3:531-40.
21. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36:131-7.
22. Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, and others. 2004. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 101:15506-11.
23. Flynn SW, Lang DJ, Mackay AL, Goghari V, Vavasour IM, Whittall KP, and others. 2003. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8:811-20.
24. Frank O, Giehl M, Zheng C, Hehlmann R, Leib-Mosch C, Seifarth W. 2005. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virol 79:10890-901.
25. Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, and others. 2004. Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res 29:1053-64.
26. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N, and others. 2005. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 ip-regulation in schizophrenia. Proc Natl Acad Sci U S A 102:15533-8.
27. Gottesman I. 1991. Schizophrenia genesis: the origins of madness. New York: W. H. Freeman.
28. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, and others. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98:4746-51.
29. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40-68.
30. Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. 2002. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 59:631-40.
31. Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, and others. 2003. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075-85.
32. Hollingshead D, Lewis DA, Mirnics K. 2005. Platform influence on DNA microarray data in postmortem brain research. Neurobiol Dis 18:649-55.
33. Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. 1999. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91:1247-55.
34. Horiuchi Y, Arai M, Niizato K, Iritani S, Noguchi E, Ohtsuki T, and others. 2006. A Polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol Psychiatry 59:434-9.
35. Iwamoto K, Bundo M, Kato T. 2005. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14:241-53.
36. Iwamoto K, Bundo M, Washizuka S, Kakiuchi C, Kato T. 2004. Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J Hum Genet 49:227-31.
37. Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T, and others. 2005. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25:5376-81.
38. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. 2004. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9:406-16.
39. Jackson ES, Wayland MT, Fitzgerald W, Bahn S. 2005. A microarray data analysis framework for postmortem tissues. Methods 37:247-60.
40. Johnston-Wilson NL, Bouton CM, Pevsner J, Breen JJ, Torrey EF, Yolken RH. 2001. Emerging technologies for large-scale screening of human tissues and fluids in the study of severe psychiatric disease. Int J Neuropsychopharmacol 4:83-92.
41. Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, and others. 2004. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 138:173-88.
42. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, and others. 2003. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 35:171-5.
43. Karlsson H. Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH. 2001. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 98:4634-9.
44. Kato T. 2001a. Molecular genetics of bipolar disorder. Neurosci Res 40:105-13.
45. Kato T. 2001b. The other, forgotten genome: mitochondrial DNA and mental disorders. Mol Psychiatry 6:625-33.
46. Kato T. 2005. Mitochondrial dysfunction in bipolar disorder: from 31P-magnetic resonance spectroscopic findings to their molecular mechanisms. Int Rev Neurobiol 63:21-40.
47. Kato T, Ishiwata M, Mori K, Washizuka S, Tajima O, Akiyama T, and others. 2003. Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol 6:379-89.
48. Kato T, Iwamoto K, Kakiuchi C, Kuratomi G, Okazaki Y. 2005. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol Psychiatry 10:622-30.
49. Kato T, Iwayama Y, Kakiuchi C, Iwamoto K, Yamada K, Minabe Y, and others. 2005. Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol Psychiatry 10:1044-55.
50. Kato T, Kato N. 2000. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180-90.
51. Katsel P, Davis KL, Gorman JM, Haroutunian V. 2005. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr Res 77:241-52.
52. Katsel P, Davis KL, Haroutunian V. 2005. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79:157-73.
53. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN. 2005. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A 102:4252-7.
54. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, and others. 1995. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28:311-8.
55. Konradi C. 2005. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev 50:142-55.
56. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. 2004. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-8.
57. Kuromitsu J, Yokoi A, Kawai T, Nagasu T, Aizawa T, Haga S, and others. 2001. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res Gene Expr Patterns 1:17-21.
58. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, and others. 2004. Systematic changes in gene expression in post-mortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13:609-16.
59. Liu X, Qui W, He G, Yang Y, Chen Q, Zhou J, and others. 2005. A family-based association study of the MOG gene with schizophrenia in the Chinese population. Schizophr Res 73:275-80.
60. Maeno-Hikichi Y, Chang S, Matsumura K, Lai M, Lin H, Nakagawa N, and others. 2003. A PKC epsilon-ENH-channel complex specifically modulates N-type Ca2+ channels. Nat Neurosci 6:468-75.
61. Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, and others. 2005. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res 139:317-32.
62. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-29.
63. Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M, and others. 2005. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet 136:12-25.
64. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, and others. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415-23.
65. Mimmack ML, Brooking J, Bahn S. 2004. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies. Biol Psychiatry 55:337-45.
66. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, and others. 2002. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A 99:4680-5.
67. Mirnics K, Levitt P, Lewis DA. 2004. DNA microarray analysis of postmortem brain tissue. Int Rev Neurobiol 60:153-81.
68. Mirnics K, Middleton FA, Lewis DA, Levitt P. 2001. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24:479-86.
69. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
70. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. 2001. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6:293-301.
71. Moises HW, Zoega T, Gottesman II. 2002. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2:8.
72. Munakata K, Iwamoto K, Bundo M, Kato T. 2005. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry 57:525-32.
73. Owen MJ, Williams NM, O'Donovan MC. 2004. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 9:14-27.
74. Pan KH, Lui CJ, Cohen SN. 2005. Effects of threshold choice on biological conclusions reached during analysis of gene expression by DNA microarrays. Proc Natl Acad Sci U S A 102:8961-5.
75. Peirce TR, Bray NJ, Williams NM, Norton N, Moskvina V, Preece A, and others. 2006. Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry 63:18-24.
76. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, and others. 2005. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 10:366-74, 28.
77. Petryshen TL, Middleton FA, Tahl AR, Rockwell GN, Purcell S, Aldinger KA, and others. 2005. Genetic investigation of chromosome 5q GABA(A) receptor subunit genes in schizophrenia. Mol Psychiatry 10:1074-88.
78. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, and others. 2004. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9:684-97, 43.
79. Qin W, Gao J, Xing Q, Yang J, Qian X, Li X, and others. 2005. A family-based association study of PLP1 and schizophrenia. Neurosci Lett 375:207-10.
80. Ryan MM, Huffaker SJ, Webster MJ, Wayland M, Freeman T, Bahn S. 2004. Application and optimization of microarray technologies for human postmortem brain studies. Biol Psychiatry 55:329-36.
81. Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, and others. 2005. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J Virol 79:341-52.
82. Sibille E, Arango V, Galfalvy HC, Pavlidis P, Erraji-Benchekroun L, Ellis SP, and others. 2004. Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29:351-61.
83. Stewart DG, Davis KL. 2004. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. Int Rev Neurobiol 59:381-424.
84. Sugai T, Kawamura M, Iritani S, Araki K, Makifuchi T, Imai C, and others. 2004. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 1025:84-91.
85. Sun X, Young LT, Wang JF, Grof P, Turecki G, Rouleau GA, and others. 2004. Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology 29:799-804.
86. Sun Y, Zhang L, Johnston NL, Torrey EF, Yolken RH. 2001. Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br J Psychiatry Suppl 41:s137-41.
87. Swatton JE, Prabakaran S, Karp NA, Lilley KS, Bahn S. 2004. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol Psychiatry 9:128-13.
88. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, and others. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798-805.
89. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, and others. 2004. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of post-mortem human brain. Biol Psychiatry 55:346-52.
90. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. 2000. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 44:151-5.
91. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, and others. 2005. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 133:1-5.
92. Unger T, Korade Z, Lazarov O, Terrano D, Sisodia SS, Mirnics K. 2005. True and false discovery in DNA microarray experiments: transcriptome changes in the hippocampus of presenilin 1 mutant mice. Methods 37:261-73.
93. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. 2004. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269-75.
94. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH 3rd, Donovan DM, and others. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55:641-50.
95. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, and others. 2002. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 58:11-20.
96. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W. 2004. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res 67:41-52.
97. Vawter MP, Shannon Weickert C, Ferran E, Matsumoto M, Overman K, Hyde TM, and others. 2004. Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 29:1245-55.
98. Wan C, Yang Y, Feng G, Gu N, Liu H, Zhu S, and others. 2005. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci Lett 388:126-31.
99. Yang YF, Qin W, Shugart YY, He G, Liu XM, Zhou J, and others. 2005. Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr Res 75:11-9.
100. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF. 2000. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 31:193-9.
101. Zai G, King N, Wigg K, Couto J, Wong GW, Honer WG, and others. 2005. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Genes Brain Behav 4:2-9.
102. Zvara A, Szekeres G, Janka Z, Kelemen JZ, Cimmer C, Santha M, and others. 2005. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Dis Markers 21:61-9.